Advertisement
INMD vs LRN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INMD is a Buy and LRN is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INMD’s FA Score shows that 0 FA rating(s) are green whileLRN’s FA Score has 2 green FA rating(s).
- INMD’s FA Score: 0 green, 5 red.
- LRN’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INMD’s TA Score shows that 3 TA indicator(s) are bullish while LRN’s TA Score has 4 bullish TA indicator(s).
- INMD’s TA Score: 3 bullish, 3 bearish.
- LRN’s TA Score: 4 bullish, 4 bearish.
Price Growth
INMD (@Medical Specialties) experienced а +3.02% price change this week, while LRN (@Miscellaneous Commercial Services) price change was -1.05% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +1.06%. For the same industry, the average monthly price growth was +2.33%, and the average quarterly price growth was -2.29%.
The average weekly price growth across all stocks in the @Miscellaneous Commercial Services industry was +0.26%. For the same industry, the average monthly price growth was +6.62%, and the average quarterly price growth was +5.24%.
Reported Earning Dates
INMD is expected to report earnings on Jul 24, 2025.
LRN is expected to report earnings on Aug 12, 2025.
Industries' Descriptions
@Medical Specialties (+1.06% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Miscellaneous Commercial Services (+0.26% weekly)The sector produces general business services, and are not classified elsewhere. For example, FleetCor Technologies provides fuel cards and workforce payment products and services; Copart, Inc. provides online vehicle auction and remarketing services across various nations; Equifax Inc. collects and aggregates credit information on consumers and businesses worldwide, along with selling credit monitoring and fraud-prevention services. Many of the companies in this category have multi-billion market capitalizations.
| INMD | LRN | INMD / LRN | |
| Capitalization | 1.82B | 2.74B | 67% |
| EBITDA | 196M | 347M | 56% |
| Gain YTD | -12.216 | 45.665 | -27% |
| P/E Ratio | 9.13 | 15.87 | 58% |
| Revenue | 492M | 1.94B | 25% |
| Total Cash | 742M | 354M | 210% |
| Total Debt | 9.02M | 542M | 2% |
INMD | LRN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 77 | 81 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 96 | 4 | |
SMR RATING 1..100 | 40 | 40 | |
PRICE GROWTH RATING 1..100 | 63 | 38 | |
P/E GROWTH RATING 1..100 | 82 | 16 | |
SEASONALITY SCORE 1..100 | 75 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
INMD's Valuation (64) in the null industry is in the same range as LRN (76) in the Other Consumer Services industry. This means that INMD’s stock grew similarly to LRN’s over the last 12 months.
LRN's Profit vs Risk Rating (4) in the Other Consumer Services industry is significantly better than the same rating for INMD (96) in the null industry. This means that LRN’s stock grew significantly faster than INMD’s over the last 12 months.
LRN's SMR Rating (40) in the Other Consumer Services industry is in the same range as INMD (40) in the null industry. This means that LRN’s stock grew similarly to INMD’s over the last 12 months.
LRN's Price Growth Rating (38) in the Other Consumer Services industry is in the same range as INMD (63) in the null industry. This means that LRN’s stock grew similarly to INMD’s over the last 12 months.
LRN's P/E Growth Rating (16) in the Other Consumer Services industry is significantly better than the same rating for INMD (82) in the null industry. This means that LRN’s stock grew significantly faster than INMD’s over the last 12 months.
| INMD | LRN | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 72% |
| Stochastic ODDS (%) | 2 days ago 76% | 2 days ago 80% |
| Momentum ODDS (%) | 2 days ago 77% | 2 days ago 65% |
| MACD ODDS (%) | 2 days ago 72% | 2 days ago 61% |
| TrendWeek ODDS (%) | 2 days ago 79% | 2 days ago 65% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 76% |
| Advances ODDS (%) | 2 days ago 78% | 12 days ago 77% |
| Declines ODDS (%) | 13 days ago 78% | 3 days ago 67% |
| BollingerBands ODDS (%) | N/A | 2 days ago 85% |
| Aroon ODDS (%) | N/A | 2 days ago 74% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GGIJX | 13.30 | 0.07 | +0.53% |
| Goldman Sachs Global Infras R6 | |||
| RMFHX | 57.47 | 0.18 | +0.31% |
| American Funds American Mutual R5E | |||
| GSUTX | 60.59 | -0.12 | -0.20% |
| Goldman Sachs US Equity Insights Inv | |||
| CAMWX | 27.45 | -0.10 | -0.36% |
| Cambiar Opportunity Inst | |||
| CGTUX | 94.23 | -0.39 | -0.41% |
| Columbia Global Technology Growth Inst3 | |||
INMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, INMD has been loosely correlated with CRL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INMD jumps, then CRL could also see price increases.
| Ticker / NAME | Correlation To INMD | 1D Price Change % | ||
|---|---|---|---|---|
| INMD | 100% | +0.48% | ||
| CRL - INMD | 43% Loosely correlated | -1.50% | ||
| IDXX - INMD | 42% Loosely correlated | -0.42% | ||
| RVTY - INMD | 41% Loosely correlated | -1.62% | ||
| CNMD - INMD | 41% Loosely correlated | -1.63% | ||
| UTMD - INMD | 41% Loosely correlated | +0.92% | ||
More | ||||
LRN and
Correlation & Price change
A.I.dvisor indicates that over the last year, LRN has been loosely correlated with LOPE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LRN jumps, then LOPE could also see price increases.
| Ticker / NAME | Correlation To LRN | 1D Price Change % | ||
|---|---|---|---|---|
| LRN | 100% | +1.73% | ||
| LOPE - LRN | 37% Loosely correlated | +1.27% | ||
| ATGE - LRN | 30% Poorly correlated | +1.73% | ||
| PRDO - LRN | 29% Poorly correlated | +3.72% | ||
| LAUR - LRN | 28% Poorly correlated | +0.58% | ||
| MMS - LRN | 27% Poorly correlated | +0.57% | ||
More | ||||